Transaction · 0002155916-26-000004

Myers Robert Paul

Myers Robert Paul, CMO, reported a transaction classified as grant at Mirum Pharmaceuticals, Inc. involving 40000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 40000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACMO
MIRMMirum Pharmaceuticals, Inc.
Trade date
Oct 09, 2026
Filing date
Oct 14, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded40.0k$0.00 per share
Holdings after40.0kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

MIRM price since this filing

Daily closing prices, with the filing date and available return windows
MIRM · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +23.5%1w ago +4.2%1d ago +2.2%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0002155916-26-000004
Employee Stock Option (right to buy)
Transaction date
Oct 09, 2026
Filed Oct 14, 2026, 08:06 PM · 5d delay
Shares
40,000 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
40,000 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    1/4th of the shares vest one year after September 21, 2026 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from th…

  2. F2

    Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

  3. F3

    1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of September 21, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three…

Original filing · 0002155916-26-000004
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

MIRM